Playback speed
10 seconds
ESMO Updates on Advanced PC: What Are the Key Survival Outcomes With Olaparib vs. Standard Hormone Therapy for mCR Disease? is Adding Abiraterone to ADT in Hormone-Naïve Disease Beneficial?
By
ecancer
FEATURING
Joaquin Mateo
By
ecancer
FEATURING
Joaquin Mateo
343 views
December 29, 2020
Login to view comments.
Click here to Login